Barclays Maintains Pacific Biosciences of California (PACB) Equal-Weight Recommendation

Fintel reports that on September 29, 2023, Barclays maintained coverage of Pacific Biosciences of California (NASDAQ:PACB) with a Equal-Weight recommendation.

admin